SUMMARY Investigations into the immunological functions of three patients with chronic mucocutaneous candidiasis were carried out. Phagocytosis of Candida albicans, nitroblue tetrazolium dye reduction, complement, and immunoglobulin levels were normal. Candidacidal assays using the neutrophils of the patients in autologous serum showed significant decreases below normal levels. This decrease in kill could be corrected by incubating the patients' cells in normal control or human AB serum. Cross-over serum studies also showed that the patients' sera had inhibitory effects on the candidacidal capacity of normal neutrophils. These changes in kill were related to candida antibody levels.
Chronic mucocutaneous candidiasis is a disorder characterized by Candida albicans infection in skin, nail, and mucous surfaces and defective cell-mediated immunity. Defective candidacidal activity by polymorphonuclear leucocytes has seldom been recognised,1 although defective intracellular killing by monocytes has been reported,2 and it has been suggested that the defect is due to a serum-dependent inhibitor.
Patients and methods
Neutrophil function was investigated in three patients (KH, JH, MR) with chronic mucocutaneous candidiasis using a micro method for the estimation of killing and phagocytosis of C. albicans.3 Antibody levels against C. albicans were determined by an indirect haemagglutination test (Roche). Other laboratory investigations included a nitroblue tetrazolium reduction test, and measurement of complement and immunoglobulin levels.4 AB serum was obtained from an untransfused male donor, and Received for publication 29 October 1979 control neutrophils and sera from normal healthy individuals.
Results
In all three patients, complement and immunoglobulin levels were normal. Nitroblue tetrazolium reduction test values, both stimulated with Escherichia coli endotoxin and unstimulated, were also normal.
Phagocytosis of C. albicans in both autologous and AB serum was normal in all three patients. The phagocytic index, estimated from the total numbers of phagocytic cells containing C. albicans, was normal in autologous and AB serum (Tables I and  2 ). The intracellular killing of C. albicans by control neutrophils in the presence of patients' sera was depressed in all three cases, when compared with that of the same neutrophils in either autologous or AB serum (see Figure) . Normal ranges for the per cent of candida phagocytosed and killed in autologous and in AB serum have been reported previously.3 Appropriate controls of heat-killed and viable candida in autologous or AB serum, in the A serum-dependent defect of neutrophil function in chronic mucocutaneous candidiasis absence of neutrophils, were included in the estimation of kill. Cross-over studies, carried out simultaneously for the detection of serum-associated defects, showed that there was also an increase in kill when patients' cells were incubated in control or AB serum, compared with that of patients' cells in autologous serum (see Figure) . The candida antibody titres for the three patients were as follows: KH, 1:1280; JH, 1:640; MR, 1:160. The level of antibody is inversely related to candidacidal activity; the higher the antibody titre, the more inhibitory the chronic mucocutaneous candidiasis serum.
Discussion
The cross-over serum studies used to assess serumassociated defects of candidacidal activity suggest that there is some inhibitory factor in the serum of these three patients with chronic mucocutaneous candidiasis. This candidacidal defect can be corrected by incubating patients' cells in 'normal' serum, either control or AB serum. These observations Normal values for the phagocytic indices of all three patients exclude a phagocytic or opsonic defect as a cause of decreased candidacidal activity.
Haemagglutination titres of up to 1:40 are considered normal in adults, whereas titres of over 1:60 are an indication of candida infection. Our evidence suggests that there is some relationship between the levels of candida antibodies and the inhibitor in chronic mucocutaneous candidiasis serum. This is unusual since antibodies are involved in the opsonisation and digestion of microorganisms and have been shown to mediate cytotoxic mechanisms. It may be that an inappropriate class or subclass of antibody is being produced and this inhibits efficient elimination of C. albicans in viito. An analogous situation exists for antibody-coated erythrocytes where the IgG subclass determines whether oI not these cells will be haemolysed and removed by the reticuloendothelial system.5 Further characterisation of the serum inhibitors 
